InsidersTradesSigma
대화제약 Stock: price and insider trades · South Korea · DART (FSS)
Track the 대화제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 대화제약 has recorded 131 insider filings. Market capitalisation: €154.3bn. The latest transaction was disclosed on 2 July 2026 (Mixed). Among the most active insiders: 김수지. The full history is free.
129
Insider Decl.
n/a
Thresholds
€69,224
17 ops.
Buy Volume
€29,868
34 ops.
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,096 of 28,065 companies
34.4
score / 100
Value37
Quality32
FCF yld0.4%
Earn yld1.0%
EV/EBITDA16.7x
ROE3.0%
Gross mgn33%
Net mgn1.2%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
Declarations131 total
Other
Other(filed)
Other
Other(filed)
25 of 131 declarations
About 대화제약
대화제약 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and distribution of pharmaceutical products.